Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alpha Tau Medical Ltd DRTS

Healthcare Medical Devices
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor... see more

Recent & Breaking News (NDAQ:DRTS)

Sidoti Events, LLC's Virtual September Small-Cap Conference

Accesswire 16 hours ago

Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor Conference

GlobeNewswire August 22, 2024

Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire August 14, 2024

Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers

GlobeNewswire June 25, 2024

Alpha Tau to Present at the Jefferies Global Healthcare Conference

GlobeNewswire May 21, 2024

Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire May 20, 2024

Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer

GlobeNewswire May 13, 2024

Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow

GlobeNewswire May 6, 2024

Alpha Tau to Participate in May Investor Conferences

GlobeNewswire May 1, 2024

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

GlobeNewswire March 25, 2024

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire March 7, 2024

Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference

GlobeNewswire February 26, 2024

Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 20, 2023

Alpha Tau to Participate in Sidoti Small-Cap Conference

GlobeNewswire November 29, 2023

Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer

GlobeNewswire November 28, 2023

Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer

GlobeNewswire November 20, 2023

Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire November 16, 2023

Alpha Tau to Participate in November Investor Conferences

GlobeNewswire November 1, 2023

Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility

GlobeNewswire October 30, 2023

Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board

GlobeNewswire October 24, 2023